blend cjc 1295 ipamorelin CJC-1295 / CJC-1295 & Ipamorelin Blend For

Liu J, Du J, Zhang Y, et al

IV therapy is generally safe and well-tolerated when administered by trained professionals

doi:10.1093/jnci/83.8.541

Details related to the statistical test, number of biological replicates, mean, standard deviation, t -values, degree of freedom, F -value, power, and p -value are available in Source Data and Supplementary Data 3

Comparing These Four Peptides | Compound | Primary Target | Main Effect | |---|---|---| | Sermorelin | GHRH Receptor | Stimulates endogenous GH release | | CJC-1295 | GHRH Receptor | Sustained GH stimulation | | Ipamorelin | Ghrelin Receptor (GHS-R1a) | Triggers GH secretion | | IGF-1 LR3 | IGF-1 Receptor | Direct tissue-level IGF signaling | For a deeper dive into the specific compounds available, see our Peptide Therapy Education page, which catalogs 23 active peptide compounds with full mechanism-of-action references